...
首页> 外文期刊>World Journal of Surgical Oncology >Primary sacral non-Hodgkin’s lymphoma: report of a case and systematic review of literature
【24h】

Primary sacral non-Hodgkin’s lymphoma: report of a case and systematic review of literature

机译:原发性骶非霍奇金的淋巴瘤:文学案例和系统审查的报告

获取原文
           

摘要

Isolated primary sacral diffuse large B cell?non-Hodgkin’s lymphoma is a very rare entity, and only 11 cases have been reported previously. A 36-year-old man was referred with low backache and radiculopathy pain with a clinico-radiological and?cytological diagnosis of sacral metastasis. Histopathological examination and immunohistochemistry of image-guided tissue core biopsy from the sacral mass confirmed it as high-grade diffuse large B cell lymphoma (DLBCL). With normal blood counts and bone marrow, and no lesions elsewhere on imaging, he was staged IAE and received 6?cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen chemotherapy followed by radiotherapy. The patient has completed a 3-year follow-up and is doing well with yearly imaging showing no evidence of active disease or recurrence. The case shows the importance of an image-guided core biopsy and immunohistochemistry over a fine needle aspiration cytology in select cases as it can alter the treatment and outcome in patients. Because of rarity, the treatment and prognosis in primary sacral NHL is not still very clear as it is treated as per the guidelines of treatment of bone lymphoma.
机译:孤立的原发性骶骨弥漫性大B细胞?非霍奇金的淋巴瘤是一种非常罕见的实体,并且以前只报告了11例。一名36岁的男子被患者患有低腰痛和无毛病疼痛,临床放射性和骶骨转移的细胞学诊断。来自骶骨质量的图像引导组织核心活组织检查的组织病理学检查和免疫组织化学证实了它作为高级漫射大B细胞淋巴瘤(DLBCL)。患有正常的血统和骨髓,并且在成像中没有病变,他被分阶段IAE并获得6?R-Chec(Rituximab,环磷酰胺,多柔比星,长春猴和泼尼松酮)方案化疗的循环,然后进行放射疗法。患者已完成3年的随访,并且每年影像都表现出不显示有源疾病或复发的证据。这种情况表明,在选择案例中,在精细针吸汗细胞学中显示图像引导的核心活检和免疫组织化学的重要性,因为它可以改变患者的治疗和结果。由于稀有性,原发性骶骨NHL的治疗和预后仍然很清楚,因为根据骨淋巴瘤的治疗指南治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号